Scarica l'app Stockscreener
0.2397
15.98%
-0.0456
Dopo l'orario di chiusura:
.23
-0.0097
-4.05%
Precedente Chiudi:
$0.2853
Aprire:
$0.27
Volume 24 ore:
40.22M
Relative Volume:
0.66
Capitalizzazione di mercato:
$37.08M
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
+22.30%
1M Prestazione:
+180.02%
6M Prestazione:
-78.21%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$0.22
$0.27
Intervallo di 1 settimana:
$0.1714
$0.4477
Portata 52W:
$0.0636
$10.95
Cero Therapeutics Holdings Inc Stock (CERO) Company Profile
Nome
Cero Therapeutics Holdings Inc
Settore
Industria
Telefono
650-407-2376
Indirizzo
201 HASKINS WAY, SOUTH SAN FRANCISCO
Confronta CERO con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
| CERO | 0.2397 | 37.08M | 0 | 0 | 0 | 0.00 |
| VRTX | 467.01 | 119.87B | 10.63B | -479.80M | -1.35B | 13.33 |
| REGN | 762.00 | 83.27B | 13.85B | 4.65B | 3.32B | 35.06 |
| ARGX | 567.90 | 33.96B | 1.86B | -40.29M | -1.28B | -4.16 |
| ALNY | 232.27 | 30.18B | 2.09B | -332.26M | 16.06M | -4.14 |
| BNTX | 101.87 | 24.42B | 3.30B | -501.07M | 1.03B | 11.54 |
Cero Therapeutics Holdings Inc Borsa (CERO) Ultime notizie
Selling Your CERo Therapeutics Holdings Inc (CERO) Stock? Here’s What You Need To Know - Stocks Register
FDA clears CERo's new AML drug for phase 1 trials - Investing.com
FDA clears CERo's new AML drug for phase 1 trials By Investing.com - Investing.com UK
CERo Therapeutics, Inc. Receives FDA Clearance of - GlobeNewswire
CERo Therapeutics Secures FDA Clearance for Novel AML Treatment Clinical Trial | CERO Stock News - StockTitan
Cero Therapeutics holdings sees $325,000 stock sale by YK Bioventures - Investing.com UK
U.S. Stock market most volatile stocks: Neuronetics(-47.27%), Heron Therapeutics(-20.15%) and LogicMark(+94.36%) in early trading - Business Upturn
United Therapeutics (UTHR) Stock Dips Amid Broader Biotech Indus - GuruFocus.com
CERo Therapeutics Holdings, Inc. (CERO): 173% Stock Surge Driven by Promising Preclinical Data for Lead Compound CER-1236 - BP Journal
Crude Oil Down 3%; Aramark Posts Upbeat Earnings - Benzinga
Nasdaq Moves Lower; Canaan Shares Surge - Benzinga
U.S. Stock market: Binah Capital Group(+105.01%) and CERo Therapeutics(+152.00%) see strong gains, RAPT Therapeutics(−44.12%) declines during mid day trading - Business Upturn
U.S. Stock market: RAPT Therapeutics drops 41% while CERo Therapeutics surges 136% in early trading - Business Upturn
Dow Jumps Over 400 Points; Monday.com Shares Fall After Q3 Results - Benzinga
CERo Therapeutics, Inc. Presents Preclinical Data - GlobeNewswire
CERo's Cancer Drug Shows Breakthrough: Kills Ovarian Cancer Without Toxicity in Key Study | CERO Stock News - StockTitan
CEROCERo Therapeutics Holdings, Inc. Latest Stock News & Market Updates - StockTitan
Cero Therapeutics faces NASDAQ delisting - Investing.com India
Cero Therapeutics faces NASDAQ delisting By Investing.com - Investing.com UK
Cero Therapeutics Faces NASDAQ Delisting Over Low Stock Price - Investing.com India
Cero Therapeutics Faces NASDAQ Delisting Over Low Stock Price By Investing.com - Investing.com UK
CERo Therapeutics updates on clinical hold and management changes - Investing.com India
CERo Therapeutics updates on clinical hold and management changes By Investing.com - Investing.com South Africa
CERo Therapeutics Holdings, Inc. Announces Submission of IND Clinical Hold Complete Response Letter - Marketscreener.com
CERo Therapeutics, Inc. Provides Corporate Update - The Bakersfield Californian
CERO’s Market Seesaw: Yearly Gains & Recent Declines – What to Expect? - The InvestChronicle
Are Investors Inclined To Sell Their CERo Therapeutics Holdings Inc. (NASDAQ: CERO) Holdings? - Stocks Register
A closer look at CERO’s price-to-free cash flow ratio - US Post News
CERo Therapeutics Holdings Inc.’s Market Journey: Closing Strong at 0.10, Up 0.63 - The Dwinnex
Take off with CERo Therapeutics Holdings Inc. (CERO): Get ready for trading - SETE News
Cero Therapeutics announces financial update and board changes - Investing.com India
Cero Therapeutics announces financial update and board changes By Investing.com - Investing.com South Africa
An analyst sees good growth prospects for CERo Therapeutics Holdings Inc. (CERO) - SETE News
CERo Therapeutics Holdings Inc. Inc. (CERO) Price Performance: The Role of Volume and Liquidity - The InvestChronicle
CERo Therapeutics Holdings Inc. (CERO) deserves closer scrutiny - US Post News
Trading Day Review: CERo Therapeutics Holdings Inc. (CERO) Gains Momentum, Closing at 0.09 - The Dwinnex
CERo Therapeutics appoints new CFO and CDO - Investing.com India
CERo Therapeutics appoints new CFO and CDO By Investing.com - Investing.com Canada
CERo Therapeutics Enhances Leadership for Clinical Advancements - TipRanks
CERo Therapeutics, Inc. Names Al Kucharchuk Chief Financial Officer and Kristen Pierce Chief Development Officer - ForexTV.com
CERo Therapeutics Holdings, Inc. Appoints Kristen Pierce as Chief Development Officer - Marketscreener.com
A Look at CERo Therapeutics Holdings Inc. (CERO) Shares in the Recent Past Indicates Growth - SETE News
Market cap of CERo Therapeutics Holdings Inc. [CERO] reaches 4.79M – now what? - The DBT News
CERo Therapeutics Holdings Inc. (CERO)’s stock price range in the last year - US Post News
Financial Fitness Check: Examining CERo Therapeutics Holdings Inc. (CERO)’s Key Ratios - The Dwinnex
Cero Therapeutics cancels special stockholder meeting By Investing.com - Investing.com Australia
Cero Therapeutics cancels special stockholder meeting - Investing.com
CERo Therapeutics Hldgs (NASDAQ:CERO) Stock Quotes, Forecast and News Summary - Benzinga
CERo Therapeutics seeks FDA meeting, reshuffles leadershi By Investing.com - Investing.com Australia
CERo Therapeutics says CEO Atwood, CFO Carter to step down - MSN
CERo Therapeutics’ Strategic Moves Amidst Leadership Change - TipRanks
Cero Therapeutics Holdings Inc Azioni (CERO) Dati Finanziari
Non sono disponibili dati finanziari per Cero Therapeutics Holdings Inc (CERO). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
3.66%
1.11%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):